Apr 23, 2025
" EDGAR Next is one of the most significant shifts in SEC filing access in decades. If you miss the enrollment deadline, you could lose...
Grabar Law Office Investigates Claims on Behalf of Shareholders of Ardelyx Inc. (ARDX)
August 14, 2023 8:29 AM EDT | Source: Grabar Law Office
Philadelphia, Pennsylvania--(Newsfile Corp. - August 14, 2023) - A securities class action complaint alleges that, Ardelyx Inc. (NASDAQ: ARDX), via certain of its officers, made materially false and misleading statements regarding tenapanor and the likelihood that it would be approved by the FDA during the Class Period, which led investors to suffer significant losses.
Current Ardelyx shareholders who have held Ardelyx shares since on or before March 6, 2020, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them.
If you would like to learn more about this matter, you are encouraged to contact us at jgrabar@grabarlaw.com, visit https://grabarlaw.com/the-latest/ardelyx-shareholder-investigation/, or call 267-507-6085.
Attorney Advertising Disclaimer
Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/177079